VANDA PHARMACEUTICALS INC.
Income Statement
| Line Item | FY2009 |
|---|---|
| Revenue | $4.5M |
| Cost of Revenue | $1.9M |
| Gross Profit | $2.6M |
| Gross Margin | 57.9% |
| Operating Expenses | |
| Research & Development | $13.9M |
| SG&A Expense | $23.7M |
| Operating Income | $-35.9M |
| Operating Margin | -790.4% |
| Interest Expense | — |
| Pretax Income | $-35.9M |
| Income Tax Expense | — |
| Net Income | $-35.9M |
| Net Margin | -788.5% |
| EPS (Basic) | $-1.33 |
| EPS (Diluted) | $-1.33 |
| Shares Outstanding (Basic) | 27.0M |
| Shares Outstanding (Diluted) | 27.0M |
| Dividends Per Share | — |